Gilead Sciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GILD and other ETFs, options, and stocks.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. 

CEO
Daniel P. O'Day
CEODaniel P. O'Day
Employees
14,400
Employees14,400
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
1987
Founded1987
Employees
14,400
Employees14,400

GILD Key Statistics

Market cap
77.32B
Market cap77.32B
Price-Earnings ratio
18.81
Price-Earnings ratio18.81
Dividend yield
4.70
Dividend yield4.70
Average volume
7.37M
Average volume7.37M
High today
$63.81
High today$63.81
Low today
$61.61
Low today$61.61
Open price
$63.32
Open price$63.32
Volume
8.79M
Volume8.79M
52 Week high
$74.12
52 Week high$74.12
52 Week low
$57.17
52 Week low$57.17

GILD News

Simply Wall St 24h
Gilead Sciences, Inc. is a favorite amongst institutional investors who own 81%

A look at the shareholders of Gilead Sciences, Inc. (NASDAQ:GILD) can tell us which group is most powerful. And the group that holds the biggest piece of the pi...

Gilead Sciences, Inc. is a favorite amongst institutional investors who own 81%
Simply Wall St 2d
The past five years for Gilead Sciences investors has not been profitable - Simply Wall St

The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to more than offset the losers At this point som...

The past five years for Gilead Sciences investors has not been profitable - Simply Wall St
Investor's Business Daily 4d
Micron Stock Wavers On Sales Miss, Weak Outlook

Reuters A federal judge in New York has frozen the assets of dozens of people and entities accused of operating a massive nationwide scheme to distribute count...

Micron Stock Wavers On Sales Miss, Weak Outlook

Analyst ratings

66%

of 29 ratings
Buy
31%
Hold
65.5%
Sell
3.4%

GILD Earnings

$0.00
$0.88
$1.77
$2.65
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Oct 27, After Hours
ActualExpected Oct 27, After Hours

More GILD News

Benzinga 4d
Gilead's Investigation Reveals Two Kingpins Directly Associated With Fake HIV Medications Scheme

U.S. District Judge Ann Donnelly has ordered to freeze several assets related to people and entities accused of operating a U.S. supply chain that distributes c...

Gilead's Investigation Reveals Two Kingpins Directly Associated With Fake HIV Medications Scheme
Reuters 4d
Gilead widens battle against alleged counterfeit HIV drug ring

FILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company is seen in Oceanside, California By Brendan Pierson (Reuters) - A federal judge in New York...

Gilead widens battle against alleged counterfeit HIV drug ring
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.